Molecular Designs

Molecular Designs is a physician-founded company based in Birmingham, Alabama, focused on developing and supplying multiplex molecular assays for research use. The company aims to simplify the delivery of molecular technologies, making them cost-effective and easy to use, particularly for PCR testing. With a team of approximately 60 employees, Molecular Designs has generated $12.7 million in revenue and holds ISO 13485:2016 certification for its Quality Management System. The company offers a range of multiplex assays designed for various PCR platforms, including the Direct-PCR Covid/Flu/RSV Simplicity Panel™. Following its merger with Lambda Biotech, Molecular Designs has enhanced its product offerings with high-quality reagents and established assays. Their services focus on direct-to-customer sales, ensuring low prices and reliable supply chains. The company is committed to improving lab profitability and efficiency through innovative solutions that support research and diagnostic goals.